Research paperFor business
AI drug discovery and genomics data infrastructure in the UK: what the evidence says about results so far
Desk research on AI-designed medicines in clinical trials, the UK's petabyte-scale genomic datasets and how they are accessed, the policy and money behind them, and what it means for small biotechs and their IT suppliers.